What To Do If You Accidentally Injected Two Doses of a GLP-1
A calm, step-by-step safety guide for the moment you realize you may have injected an extra shot.
Maybe you drew up your weekly shot, got distracted, and then could not remember whether you had already done it. Maybe the pen clicked twice. Maybe two people in the house share a similar routine and the signals got crossed. Whatever happened, you now think you may have injected an extra or double dose of your GLP-1, and your stomach is in knots for reasons that have nothing to do with the medicine yet. Take a breath. This is a common worry, it is usually manageable, and there is a clear path for what to do next.
First, the one action that matters most
If you think you took an extra or double dose, reach a professional rather than trying to sort it out alone. Two good options exist, and you can use both. Call your prescriber's office and tell them exactly what happened. And in the United States you can call Poison Control at 1-800-222-1222, a free and confidential line staffed 24 hours a day, 7 days a week by people trained for exactly this question. You do not need to be in a crisis to call. Poison centers handle routine dosing questions constantly and can tell you whether you need to be seen or can safely monitor at home.
This is not a rare or obscure worry, either. US poison centers have reported a sharp rise in calls about injectable weight-loss medicines in recent years, close to a 1,500% increase over one reporting period. You are not the first person to make this call, and the person who answers will not be surprised.
When to skip the phone and get emergency care
Some symptoms mean you should not wait on hold. Call 911 or go to the nearest emergency department if, after an extra or double dose, you have any of the following:
Ready to start?
$199 Skeptics' Trial, see if it works for you
One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.
Start the 30-day trial- Vomiting that will not stop, or an inability to keep any fluids down
- Signs of dehydration such as dizziness, a racing heart, very little urine, or feeling faint when you stand
- Fainting or near-fainting
- Severe or steady abdominal pain, especially pain that bores through to your back
- Symptoms of low blood sugar (shakiness, sweating, confusion, a pounding heart) if you also take insulin or a sulfonylurea
When in doubt, lean toward being seen. It is always reasonable to let a clinician lay eyes on you.
What an overdose of these medicines actually looks like
Here is the reassuring part. A GLP-1 does not produce a dramatic, immediate toxic effect the way some drugs do. The trouble it causes is mostly an amplified version of side effects you may already recognize. In reports collected by the FDA for injectable semaglutide, the most common problems after a dosing error were gastrointestinal: heavy nausea, vomiting, and abdominal pain. Some people also reported fainting, headache, or migraine, along with dehydration from all the vomiting. In a smaller number of cases there were more serious events such as acute pancreatitis or gallstones, and some people needed hospital care. That wide range is exactly why a trained professional, not a blog post, should be the one to tell you which category you are in.
The low-blood-sugar question, answered honestly
People often assume a double dose will crash their blood sugar. For most patients on a GLP-1 by itself, that is not the main concern, because these medicines carry a low built-in chance of causing hypoglycemia on their own. The picture changes if you also take insulin or an insulin secretagogue such as a sulfonylurea. The Mounjaro (tirzepatide) label specifically warns that combining a GLP-1 with those medicines may raise the risk of low blood sugar, including severe low blood sugar. If that describes you, learn the warning signs now and watch for them closely after an extra dose. Our deeper explainer on GLP-1 and low blood sugar walks through what to feel for and why the combination is the part that matters.
Why symptoms can linger for days
These are long-acting medicines. Semaglutide has a half-life of roughly one week, and tirzepatide about five days. That means an overdose does not simply clear in a few hours. Nausea and vomiting can stretch across several days, so dehydration becomes something to monitor over that whole span rather than just the first evening. The FDA-approved Ozempic label states it plainly in its overdose section: there is no specific antidote, care is supportive and guided by your symptoms, and a prolonged period of observation may be necessary given the roughly one-week half-life. No reversal agent exists, so the plan is steady monitoring, fluids, and treating symptoms as they come. If you already feel rough, our notes on how we handle side effects and our GLP-1 sick-day guidance cover hydration and when to check back in.
The rule that prevents most of these calls: never double up
A lot of accidental double doses start from a well-meant instinct to catch up after a missed week. Please do not. The labeling for these medicines builds in specific missed-dose windows instead of doubling. For Mounjaro (tirzepatide), a missed dose can generally be taken within 4 days (96 hours), and after that it is skipped and the normal schedule resumes. Weekly semaglutide has its own defined window. The exact right move depends on your product, your schedule, and your prescriber, so we will not hand you a formula here. We will simply state the firm part clearly: taking two doses close together to make up for a missed one is the thing to avoid. If you missed a shot and are unsure what to do, read what if you miss a GLP-1 dose and then check with the person who prescribes it.
A special word on compounded vials
Many dosing errors trace back to how the dose is measured. When the FDA reviewed dosing mistakes with compounded injectable semaglutide, it found that some patients had received 5 to 10 times the intended amount, often from confusion converting milligrams into units or milliliters, or from unfamiliarity with drawing a dose from a vial and syringe. That is a different setup from a prefilled pen that meters the dose for you. It is worth being honest here: compounded semaglutide and tirzepatide are not FDA-approved and not brand-identical, and results vary from person to person. If you use a compounded vial and are ever unsure how much you actually drew, that uncertainty by itself is a good reason to call your prescriber or Poison Control.
How we think about it at New Hope
Dr. Anjmun Sharma, MD tells patients the same thing we are telling you here. An accidental extra shot is usually not an emergency, but it is also not something to guess your way through. Tell us, or tell Poison Control, what happened, and let a trained person help you decide whether to watch and hydrate at home or be seen. Save 1-800-222-1222 in your phone today, before you ever need it. Knowing the number is already there tends to take the panic out of the moment, and a calm, informed response is almost always the safest one.
This article is educational and is not a substitute for professional medical advice. Ozempic and Wegovy are trademarks of Novo Nordisk; Mounjaro and Zepbound are trademarks of Eli Lilly. New Hope Weight Loss and Wellness is not affiliated with or endorsed by either company.
Frequently asked questions
I took my GLP-1 twice by accident. Is that dangerous?
A single extra shot is often not life-threatening, but it is not something to guess about. The main effects tend to be strong nausea, vomiting, and abdominal pain, and risk rises with larger amounts, compounded vials, or if you also take insulin or a sulfonylurea. Do not assume it is harmless and do not assume it is a disaster. Call your prescriber's office or US Poison Control at 1-800-222-1222 so a trained person can judge your specific situation, and get emergency care for severe symptoms.
What number do I call if I took too much semaglutide or tirzepatide?
In the United States, call Poison Control at 1-800-222-1222. It is free, confidential, and staffed 24 hours a day, 7 days a week, and FDA labeling for both semaglutide and tirzepatide names this line for overdose questions. You can also call your prescriber. For severe symptoms such as nonstop vomiting, fainting, or severe abdominal pain, call 911 or go to the emergency department.
Can a double dose of a GLP-1 cause low blood sugar?
For most people taking a GLP-1 on its own, low blood sugar is not the main concern, because these medicines carry a low built-in risk of it. The real danger appears when a GLP-1 is combined with insulin or an insulin secretagogue such as a sulfonylurea. The Mounjaro (tirzepatide) label warns that this combination can raise the risk of low blood sugar, including severe cases. If you take those medicines, watch closely for shakiness, sweating, confusion, or a pounding heart, and seek care if they appear.
How long will symptoms from an extra dose last?
Possibly several days. Semaglutide has a half-life of about one week and tirzepatide about five days, so an overdose does not clear in a few hours. Nausea and vomiting can persist, which is why hydration and monitoring matter over the whole stretch. There is no antidote; the FDA-approved labeling describes supportive care guided by your symptoms. If vomiting will not stop or you show signs of dehydration, get urgent care rather than waiting it out.
I missed a dose. Can I just take two next time to catch up?
No. Do not double up to make up for a missed dose. The labeling builds in defined missed-dose windows instead. For Mounjaro (tirzepatide), a missed dose can generally be taken within 4 days (96 hours), otherwise it is skipped; weekly semaglutide has its own window. The exact right step depends on your product and schedule, so ask your prescriber rather than doubling. Our post on what to do if you miss a GLP-1 dose walks through it in more detail.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.